Sol-Gel Technologies (SLGL) - Cash on Hand per Share

The cash per share metric for Sol-Gel Technologies (SLGL) on GURU.Markets demonstrates current liquidity, where this figure equals 13.56, correlating with the development of partnerships to bring dermatological innovations to market. The business foundation relies on Israeli laboratories while outsourcing production to the US. License royalties from global pharmaceutical behemoths guarantee revenue stability.
Comprehensive metric breakdowns and analytics for Sol-Gel Technologies, Ltd. (SLGL)

The metric is calculated by dividing the total amount of cash and cash equivalents by the number of shares outstanding. This metric determines the actual liquid value of an investor's stake, separating tangible capital from estimated assets. For Sol-Gel Technologies (SLGL), this is critical, as reliance on royalties and distributors creates uneven cash flows. By analyzing the cash per share chart, one can assess the company's resilience to market volatility. Here, reserves serve as a survival guarantee given the limited control over final pricing power.